Paul-Ehrlich-Institut

Coronavirus and COVID-19

Proof of Vaccination as Defined in the COVID-19 Protective Measures Exemption Directive and the Directive on Coronavirus Entry Regulations

Persuant to section 2 sentence 3 of the COVID-19 Protective Measures Exemption Directive (SchAusnahmV) and section 2 sentence 10 of the Directive on Coronavirus Entry Regulation (CoronaEinreiseV), proof of complete vaccination protection against the SARS-CoV-2 coronavirus exists if the underlying protective vaccination was given with one or more of the vaccines listed below, and

  • a) consists of the number of doses of vaccine published herein required for complete protective vaccination and at least 14 days have elapsed since the last required single vaccination; or
  • b) in the case of a recovered person with proof of recovery, consists of one dose of vaccine administered.

For the purposes of a), a single dose of vaccine with one of the vaccines listed below is sufficient if the person concerned can provide evidence of a specific positive antibody test carried out on him/her in embodied or digital form in English, French, German, Italian or Spanish and this test was carried out at a time when the person concerned had not yet received vaccination against COVID-19.

The laboratory diagnostic findings must be documented in a laboratory test certificate issued in accordance with the guideline of the Federal Medical Association for quality assurance of laboratory medical examinations (Richtlinie der Bundesärztekammer zur Qualitätssicherung laboratoriumsmedizinischer Untersuchungen, RiLiBÄK) or in a laboratory accredited according to DIN EN ISO 15189.

For the purposes b), evidence of recovery is the evidence of the presence of previous SARS-CoV-2 coronavirus infection in the affected person in embodied or digital form in English, French, German, Italian or Spanish, if the underlying testing has been performed by laboratory diagnosis using nucleic acid detection (PCR, PoC-PCR or other methods of nucleic acid amplification technology).

Requirements for full vaccine protection with one vaccine

VaccineMarketing Authorisation HolderNumber of vaccine doses for complete vaccination
Comirnaty
Authorisation No. EU/1/20/1528
BioNTech Manufacturing GmbH2
Spikevax
Authorisation No. EU/1/20/1507
Moderna Biotech Spain, S.L.2
Vaxzevria
Authorisation No. EU/1/21/1529
AstraZeneca AB, Schweden2
COVID-19 Vaccine Janssen
Authorisation No. EU/1/20/1525
Janssen-Cilag International NV1

Requirements for complete vaccination protection with different vaccines (heterologous vaccination scheme)

Vaccination 1Vaccination 2Number of vaccine doses for complete vaccination
Vaxzevria
Authorisation No. EU/1/21/1529
Comirnaty
Authorisation No. EU/1/20/1528
2
Vaxzevria
Authorisation No. EU/1/21/1529
Spikevax
Authorisation No. EU/1/20/1507
2
Comirnaty
Authorisation No. EU/1/20/1528
Spikevax
Authorisation No. EU/1/20/1507
2
Spikevax
Authorisation No. EU/1/20/1507
Comirnaty
Authorisation No. EU/1/20/1528
2

List of authorisations and vaccine product names in third countries (outside the EU and EEA)

Versions of EU-authorised vaccines which are authorised abroad (original or licensed productions) are equivalent to the above-mentioned EU-authorised vaccines for the purposes of demonstrating vaccine protection. For further information, please refer to the list below.

Comirnaty

State / Community of States / Organisation (German notation)Product Name
AlbanienCOMIRNATY
AlgerienPfizer-BioNTech COVID-19 vaccine
ArgentinienCOMIRNATY
AustralienCOMIRNATY
BahrainPfizer-BioNTech COVID-19 vaccine
BrasilienCOMIRNATY
ChilePfizer-BioNTech COVID-19 vaccine
Costa RicaPfizer-BioNTech COVID-19 vaccine
Dominikanische RepublikPfizer-BioNTech COVID-19 vaccine
EcuadorPfizer-BioNTech COVID-19 vaccine
El SalvadorPfizer-BioNTech COVID-19 vaccine
EU (all member states)Comirnaty
GeorgienPfizer-BioNTech COVID-19 vaccine
HondurasPfizer-BioNTech COVID-19 vaccine
HongkongCOMIRNATY
IrakPfizer-BioNTech COVID-19 vaccine
IslandComirnaty
IsraelPfizer-BioNTech COVID-19 vaccine
JapanCOMIRNATY
JordanienPfizer-BioNTech COVID-19 vaccine
KanadaPfizer-BioNTech COVID-19 vaccine
KatarPfizer-BioNTech COVID-19 vaccine
KolumbienPfizer-BioNTech COVID-19 vaccine
KosovoCOMIRNATY
KuwaitPfizer-BioNTech COVID-19 vaccine
LibanonPfizer-BioNTech COVID-19 vaccine
LiechtensteinComirnaty
MacauCOMIRNATY
MalaysiaCOMIRNATY
MexikoPfizer-BioNTech COVID-19 vaccine
MoldawienCOMIRNATY
MongoleiPfizer-BioNTech COVID-19 vaccine
NeuseelandCOMIRNATY
NordmazedonienCOMIRNATY
NorwegenComirnaty
OmanPfizer-BioNTech COVID-19 vaccine
PakistanCOMIRNATY
PalästinaCOMIRNATY
PanamaPfizer-BioNTech COVID-19 vaccine
ParaguayPfizer-BioNTech COVID-19 vaccine
PeruCOMIRNATY
PhilippinenPfizer-BioNTech COVID-19 vaccine
RuandaCOMIRNATY
Saudi-ArabienPfizer-BioNTech COVID-19 vaccine
SchweizCOMIRNATY
SerbienCOMIRNATY
SingapurPfizer-BioNTech COVID-19 vaccine
Sri LankaCOMIRNATY
SüdafrikaCOMIRNATY
SüdkoreaCOMIRNATY
SwasilandCOMIRNATY
TunesienPfizer-BioNTech COVID-19 vaccine
TürkeiPfizer-BioNTech COVID-19 vaccine
UkraineCOMIRNATY
UruguayPfizer-BioNTech COVID-19 vaccine
USAPfizer-BioNTech COVID-19 vaccine
Vereinigte Arabische EmiratePfizer-BioNTech COVID-19 vaccine
Vereinigtes KönigreichPfizer-BioNTech COVID-19 vaccine,
COMIRNATY
VietnamCOMIRNATY

COVID-19 Vaccine Janssen

State / Community of States / Organisation (German notation)Product Name
Afrikanische UnionCOVID-19 Vaccine Janssen
AngolaCOVID-19 Vaccine Janssen
ÄthiopienCOVID-19 Vaccine Janssen
BahrainCOVID-19 Vaccine Janssen
BotswanaCOVID-19 Vaccine Janssen
BrasilienJanssen COVID-19 Vaccine / Vacina covid-19 (recombinante)
Cabo VerdeCOVID-19 Vaccine Janssen 
ChileCOVID-19 Vaccine Janssen
Dem. Republik KongoCOVID-19 Vaccine Janssen
EU (all member states)COVID-19 Vaccine Janssen
GambiaCOVID-19 Vaccine Janssen
GhanaCOVID-19 Vaccine Janssen
Guinea-BissauCOVID-19 Vaccine Janssen
IslandCOVID-19 Vaccine Janssen
JordanienCOVID-19 Vaccine Janssen 
KanadaJanssen COVID-19 Vaccine
KatarCOVID-19 Vaccine Janssen 
KolumbienJanssen COVID-19 Vaccine / COVID-19 Vaccine Janssen
KongoCOVID-19 Vaccine Janssen
KuwaitCOVID-19 Vaccine Janssen
LesothoCOVID-19 Vaccine Janssen
LiberiaCOVID-19 Vaccine Janssen
LibyenCOVID-19 Vaccine Janssen
LiechtensteinCOVID-19 Vaccine Janssen
MadagaskarCOVID-19 Vaccine Janssen
MalawiCOVID-19 Vaccine Janssen
MalaysiaCOVID-19 Vaccine Janssen Suspension for Injection
MaliCOVID-19 Vaccine Janssen
MexikoJanssen COVID-19 Vaccine / COVID-19 Vaccine Janssen
NamibiaCOVID-19 Vaccine Janssen
NigeriaCOVID-19 Vaccine Janssen
NorwegenCOVID-19 Vaccine Janssen
PhilippinenJanssen COVID-19 Vaccine
Republik KoreaCOVID-19 Vaccine Janssen
RuandaCOVID-19 Vaccine Janssen 
SambiaCOVID-19 Vaccine Janssen 
Sao Tome und PrincipeCOVID-19 Vaccine Janssen
Saudi-ArabienCOVID-19 Vaccine Janssen
SchweizCOVID-19 Vaccine Janssen
SenegalCOVID-19 Vaccine Janssen
SüdafrikaCOVID-19 Vaccine Janssen
ThailandCOVID-19 Vaccine Janssen / Janssen COVID-19 Vaccine
TogoCOVID-19 Vaccine Janssen
TunesienCOVID-19 Vaccine Janssen
USAJanssen COVID-19 Vaccine
Vereinigtes KönigreichCOVID-19 Vaccine Janssen
WHOCOVID-19 Vaccine Janssen
Zentralafrikanische RepublikCOVID-19 Vaccine Janssen

Spikevax (formerly: COVID-19 Vaccine Moderna)

State / Community of States / Organisation (German notation)Product Name
BotswanaCovid-19 Vaccine Moderna Dispersion for injection
BruneiModerna Covid-19 Vaccine (mRNA-1273 Vaccine)
EU (all member states)Spikevax (formerly: COVID-19 Vaccine Moderna)
IslandSpikevax (formerly: COVID-19 Vaccine Moderna)
IsraelCovid-19 Vaccine Moderna Dispersion for injection
JapanCovid-19 Vaccine Moderna Intramuscular injection
JordanienCovid-19 Vaccine Moderna
KanadaCovid-19 Vaccine Moderna Dispersion for injection
KatarCovid-19 Vaccine Moderna Dispersion for injection
LiechtensteinSpikevax (formerly: COVID-19 Vaccine Moderna)
NorwegenSpikevax (formerly: COVID-19 Vaccine Moderna)
Paraguayn/a
PhilippinenCovid-19 Vaccine Moderna
SchweizCovid-19 Vaccine Moderna Dispersion for injection
SingapurCovid-19 Vaccine Moderna Dispersion for injection
SüdkoreaCovid-19 Vaccine Moderna
TaiwanModerna Covid-19 Vaccine
ThailandCovid-19 Vaccine Moderna
USAModerna Covid-19 Vaccine Suspension for injection
Vereinigtes KönigreichCovid-19 Vaccine Moderna Dispersion for injection
WHOCovid-19 Vaccine Moderna

Vaxzevria (formerly: COVID-19 Vaccine AstraZeneca)

State / Community of States / Organisation (German notation)Product NameCompany
ÄgyptenCovishieldSerum Institute of India (AstraZeneca licensee)
ArgentinienCovid-19 Vaccine, ASTRAZENECA ®AstraZeneca
ArgentinienCovishieldSerum Institute of India (AstraZeneca licensee)
AustralienCOVID-19 Vaccine AstraZenecaAstraZeneca
BahrainR-CoVIR-PHARM (AstraZeneca licensee)
BahrainCovishieldSerum Institute of India (AstraZeneca licensee)
BangladeshCovishieldSerum Institute of India (AstraZeneca licensee)
BotswanaCovishieldSerum Institute of India (AstraZeneca licensee)
BrasilienCovid-19 Vaccine AstraZeneca/VaxzevriaAstraZeneca
BrasilienCovid-19 vaccine (recombinant)FUNDAÇÃO Instituto OSWALDO CRUZ (FIOCRUZ) (AstraZeneca licensee)
BrasilienCovishieldSerum Institute of India (AstraZeneca licensee)
BruneiCovid-19 Vaccine AstraZeneca/VaxzevriaAstraZeneca
ChileCovid-19 Vaccine AstraZeneca/VaxzevriaAstraZeneca
Costa RicaCovid-19 Vaccine AstraZeneca/VaxzevriaAstraZeneca
Dominikanische RepublikCovid-19 Vaccine AstraZenecaAstraZeneca
Dominikanische RepublikCovishieldSerum Institute of India (AstraZeneca licensee)
Dubai (UAE)R-CoVIR-PHARM (AstraZeneca licensee)
EcuadorVacuna AstraZeneca COVID-19 / Covid-19 Vaccine AstraZenecaAstraZeneca
El SalvadorCOVID-19 Vaccine AstraZenecaAstraZeneca
El SalvadorCovishieldSerum Institute of India (AstraZeneca licensee)
EU (alle Mitgliedstaaten)Vaxzevria (ehemals: COVID-19 Vaccine AstraZeneca)AstraZeneca
GambiaCovishieldSerum Institute of India (AstraZeneca licensee)
GhanaCovishieldSerum Institute of India (AstraZeneca licensee)
HondurasCOVID-19 Vaccine AstraZenecaAstraZeneca
IndienCovishieldSerum Institute of India (AstraZeneca licensee)
IndonesienCOVID-19 Vaccine AstraZenecaAstraZeneca
IranR-CoVIR-PHARM (AstraZeneca licensee)
IslandVaxzevria (ehemals: COVID-19 Vaccine AstraZeneca)AstraZeneca
IsraelCovid-19 Vaccine AstraZeneca/VaxzevriaAstraZeneca
JapanCovid-19 Vaccine AstraZeneca/VaxzevriaAstraZeneca
JordanienR-CoVIR-PHARM (AstraZeneca licensee)
JordanienCovishieldSerum Institute of India (AstraZeneca licensee)
KanadaAstraZeneca COVID-19 Vaccine (AZD1222)
COVISHIELD Vaccine
AstraZeneca
KeniaCovishieldSerum Institute of India (AstraZeneca licensee)
KolumbienCovid-19 Vaccine AstraZeneca AstraZeneca
KuwaitR-CoVIR-PHARM (AstraZeneca licensee)
KuwaitCovishieldSerum Institute of India (AstraZeneca licensee)
LibanonR-CoVIR-PHARM (AstraZeneca licensee)
LiechtensteinVaxzevria (ehemals: COVID-19 Vaccine AstraZeneca)AstraZeneca
MacauCovid-19 Vaccine AstraZeneca/VaxzevriaAstraZeneca
MalaysiaCOVID-19 Vaccine AstraZenecaAstraZeneca
MaledivenCovid-19 Vaccine AstraZeneca/VaxzevriaAstraZeneca
MaledivenCovishieldSerum Institute of India (AstraZeneca licensee)
MarokkoR-CoVIR-PHARM (AstraZeneca licensee)
MarokkoCovishieldSerum Institute of India (AstraZeneca licensee)
MexikoVacuna AstraZeneca COVID-19AstraZeneca
MongoleiR-CoVIR-PHARM (AstraZeneca licensee)
MontenegroCovid-19 Vaccine AstraZeneca/VaxzevriaAstraZeneca
MyanmarCovishieldSerum Institute of India (AstraZeneca licensee)
NamibiaCovishieldSerum Institute of India (AstraZeneca licensee)
NauruCovishieldSerum Institute of India (AstraZeneca licensee)
NepalCovishieldSerum Institute of India (AstraZeneca licensee)
NeuseelandCovid-19 Vaccine AstraZeneca/VaxzevriaAstraZeneca
NicaraguaCovishieldSerum Institute of India (AstraZeneca licensee)
NigeriaCovishieldSerum Institute of India (AstraZeneca licensee)
NorwegenVaxzevria (ehemals: COVID-19 Vaccine AstraZeneca)AstraZeneca
OmanR-CoVIR-PHARM (AstraZeneca licensee)
OmanCovishieldSerum Institute of India (AstraZeneca licensee)
PakistanCovishieldSerum Institute of India (AstraZeneca licensee)
PalästinaR-CoVIR-PHARM (AstraZeneca licensee)
PalästinaCovishieldSerum Institute of India (AstraZeneca licensee)
PanamaCOVID-19 Vaccine AstraZenecaAstraZeneca
PhilippinenCOVID-19 Vaccine AstraZenecaAstraZeneca
RuandaCovishieldSerum Institute of India (AstraZeneca licensee)
Saudi-ArabienCovishieldSerum Institute of India (AstraZeneca licensee)
SchweizCovid-19 Vaccine AstraZeneca/VaxzevriaAstraZeneca
SenegalCovishieldSerum Institute of India (AstraZeneca licensee)
SerbienCovid-19 Vaccine AstraZeneca/VaxzevriaAstraZeneca
SingapurCovid-19 Vaccine AstraZeneca/VaxzevriaAstraZeneca
Sri LankaCovishieldSerum Institute of India (AstraZeneca licensee)
SüdafrikaCovishieldSerum Institute of India (AstraZeneca licensee)
SüdkoreaAstraZeneca Korea COVID-19 VaccineAstraZeneca
TaiwanCOVID-19 Vaccine AstraZenecaAstraZeneca
ThailandCOVID-19 Vaccine AstraZenecaAstraZeneca
TurkmenistanR-CoVIR-PHARM (AstraZeneca licensee)
UkraineCovishieldSerum Institute of India (AstraZeneca licensee)
UkraineCovid-19 Vaccine AstraZeneca/VaxzevriaAstraZeneca
UngarnAstra ChAdOx1 SAstraZeneca
UruguayCOVID-19 Vaccine AstraZenecaAstraZeneca
Vereinigtes KönigreichCovid-19 Vaccine AstraZeneca/VaxzevriaAstraZeneca
VietnamCOVID-19 Vaccine AstraZenecaAstraZeneca
WHOCOVID-19 Vaccine AstraZenecaAstraZeneca

WHO EUL (Emergency Use Listing)

Product NameCompany
AZD1222AstraZeneca
BNT162b2/COMIRNATY, Tozinameran (INN)BioNTech/Pfizer
Covishield (ChAdOx1_nCoV-19)Serum Institute of India (AstraZeneca licensee)
mRNA-1273Moderna

List of authorisations and vaccine product names in third countries (outside the EU and EEA) - As of 29 July 2021

The list is for information only and does not claim to be complete. It is the responsibility of the person wishing to enter the country to prove that he or she has been fully vaccinated with a recognised EU-approved vaccine as defined in the Directive of Coronavirus Entry Regulation (Coronavirus-Einreiseverordnung - CoronaEinreiseV).

Content

  1. Role of the Paul-Ehrlich-Institut
  2. COVID-19 Vaccines
  3. Proof of Vaccination as Defined in the COVID-19 Protective Measures Exemption Directive and the Directive on Coronavirus Entry Regulations
  4. FAQ Coronavirus
  5. Biomedicines
  6. Safety of COVID-19 Vaccines
  7. Research Work
  8. SARS-CoV-2 Test Systems